| pubmed-article:19160361 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19160361 | lifeskim:mentions | umls-concept:C0023895 | lld:lifeskim |
| pubmed-article:19160361 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:19160361 | lifeskim:mentions | umls-concept:C0080103 | lld:lifeskim |
| pubmed-article:19160361 | lifeskim:mentions | umls-concept:C0206754 | lld:lifeskim |
| pubmed-article:19160361 | lifeskim:mentions | umls-concept:C0494165 | lld:lifeskim |
| pubmed-article:19160361 | lifeskim:mentions | umls-concept:C0439792 | lld:lifeskim |
| pubmed-article:19160361 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:19160361 | pubmed:dateCreated | 2009-1-27 | lld:pubmed |
| pubmed-article:19160361 | pubmed:abstractText | Hepatic surgery is presumed to improve survival of patients with liver metastases (LM) from neuroendocrine tumours (NET). This study identified LM-specific variables that could be used as additional selection criteria for aggressive treatment. | lld:pubmed |
| pubmed-article:19160361 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19160361 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19160361 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19160361 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:19160361 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19160361 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19160361 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19160361 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19160361 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19160361 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:19160361 | pubmed:issn | 1365-2168 | lld:pubmed |
| pubmed-article:19160361 | pubmed:author | pubmed-author:BockischAA | lld:pubmed |
| pubmed-article:19160361 | pubmed:author | pubmed-author:OOIS KSK | lld:pubmed |
| pubmed-article:19160361 | pubmed:author | pubmed-author:BroelschC ECE | lld:pubmed |
| pubmed-article:19160361 | pubmed:author | pubmed-author:FrillingAA | lld:pubmed |
| pubmed-article:19160361 | pubmed:author | pubmed-author:MalamutmannEE | lld:pubmed |
| pubmed-article:19160361 | pubmed:author | pubmed-author:SchmidK-WKW | lld:pubmed |
| pubmed-article:19160361 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19160361 | pubmed:volume | 96 | lld:pubmed |
| pubmed-article:19160361 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19160361 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19160361 | pubmed:pagination | 175-84 | lld:pubmed |
| pubmed-article:19160361 | pubmed:dateRevised | 2009-6-22 | lld:pubmed |
| pubmed-article:19160361 | pubmed:meshHeading | pubmed-meshheading:19160361... | lld:pubmed |
| pubmed-article:19160361 | pubmed:meshHeading | pubmed-meshheading:19160361... | lld:pubmed |
| pubmed-article:19160361 | pubmed:meshHeading | pubmed-meshheading:19160361... | lld:pubmed |
| pubmed-article:19160361 | pubmed:meshHeading | pubmed-meshheading:19160361... | lld:pubmed |
| pubmed-article:19160361 | pubmed:meshHeading | pubmed-meshheading:19160361... | lld:pubmed |
| pubmed-article:19160361 | pubmed:meshHeading | pubmed-meshheading:19160361... | lld:pubmed |
| pubmed-article:19160361 | pubmed:meshHeading | pubmed-meshheading:19160361... | lld:pubmed |
| pubmed-article:19160361 | pubmed:meshHeading | pubmed-meshheading:19160361... | lld:pubmed |
| pubmed-article:19160361 | pubmed:meshHeading | pubmed-meshheading:19160361... | lld:pubmed |
| pubmed-article:19160361 | pubmed:meshHeading | pubmed-meshheading:19160361... | lld:pubmed |
| pubmed-article:19160361 | pubmed:meshHeading | pubmed-meshheading:19160361... | lld:pubmed |
| pubmed-article:19160361 | pubmed:meshHeading | pubmed-meshheading:19160361... | lld:pubmed |
| pubmed-article:19160361 | pubmed:meshHeading | pubmed-meshheading:19160361... | lld:pubmed |
| pubmed-article:19160361 | pubmed:meshHeading | pubmed-meshheading:19160361... | lld:pubmed |
| pubmed-article:19160361 | pubmed:meshHeading | pubmed-meshheading:19160361... | lld:pubmed |
| pubmed-article:19160361 | pubmed:meshHeading | pubmed-meshheading:19160361... | lld:pubmed |
| pubmed-article:19160361 | pubmed:meshHeading | pubmed-meshheading:19160361... | lld:pubmed |
| pubmed-article:19160361 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19160361 | pubmed:articleTitle | Treatment of liver metastases from neuroendocrine tumours in relation to the extent of hepatic disease. | lld:pubmed |
| pubmed-article:19160361 | pubmed:affiliation | Department of General, Visceral and Transplantation Surgery, University Hospital Essen, Essen, Germany. andrea.frilling@usz.ch | lld:pubmed |
| pubmed-article:19160361 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19160361 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19160361 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19160361 | lld:pubmed |
